Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
12.01
+0.31 (2.65%)
At close: Jul 27, 2026, 4:00 PM EDT
12.03
+0.02 (0.17%)
After-hours: Jul 27, 2026, 5:16 PM EDT
Olema Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Olema Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $40.7. The average 1-year stock price forecast is 238.88% higher than the current stock price, while the lowest is $23 (+91.51%) and the highest is $62 (+416.24%).
Price Target: $40.7 (+238.88%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Olema Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 13 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $24 | Buy | Maintains | $24 | +99.83% | Jul 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $38 | Buy | Reiterates | $38 | +216.40% | Jun 3, 2026 |
| UBS | UBS | Buy Maintains $45 | Buy | Maintains | $45 | +274.69% | Jun 2, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $38 → $35 | Buy | Maintains | $38 → $35 | +191.42% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
23.12M
EPS This Year
-2.27
from -1.87
EPS Next Year
-2.48
from -2.27
EPS and Forward PE are based on non-GAAP adjusted numbers.